Edit |   |
Antigenic Specificity | POU3F2 (Center), 199-226 |
Clone | polyclonal |
Host Species | Rabbit |
Reactive Species | human (predicted reactivity: mouse, rat) |
Isotype | n/a |
Format | peptide affinity purified |
Size | 0.08 mL, 0.4 mL |
Concentration | vial concentration: 0.45 |
Applications | Western Blot (WB), ELISA (EIA) |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | This POU3F2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 199-226 amino acids from the Central region of human POU3F2. POU3F2 belongs to a large family of transcription factorsthat bind to the octameric DNA sequence ATGCAAAT. Most of theseproteins share a highly homologous region, referred to as the POUdomain, that occurs in several mammalian transcription factors,including the octamer-binding proteins Oct1 (POU2F1; MIM 164175)and Oct2 (POU2F2; MIM 164176) and the pituitary protein Pit1 (PIT1;MIM 173110). Class III POU genes are expressed predominantly in thecentral nervous system (CNS). It is likely that CNS-specifictranscription factors such as these pl |
Immunogen | n/a |
Other Names | [POU domain; class 3; transcription factor 2; Brain-specific homeobox/POU domain protein 2; Brain-2; Brn-2; Nervous system-specific octamer-binding transcription factor N-Oct-3; Octamer-binding protein 7; Oct-7; Octamer-binding transcription factor 7; OTF-7; POU3F2; BRN2; OCT7; OTF7] |
Gene, Accession # | [POU3F2], Gene ID: 5454, NCBI: NP_005595.2, UniProt: P20265 |
Catalog # | MBS9214671 |
Price | $165, $370 |
Order / More Info | POU3F2 (Center), 199-226 Antibody from MYBIOSOURCE INC. |
Product Specific References | Kobi, D., et al. Pigment Cell Melanoma Res 23(3):404-418(2010) Flammiger, A., et al. J. Invest. Dermatol. 129(4):945-953(2009) Cabos-Siguier, B., et al. Protein Expr. Purif. 64(1):39-46(2009) Lowe, J.K., et al. PLoS Genet. 5 (2), E1000365 (2009) : Potkin, S.G., et al. Schizophr Bull 35(1):96-108(2009) |